Aglowmed Limited - pharma in Patna, Bihar, India. FY 2026 financials & compliance.
CIN U24232BR1983PLC001901 Incorporated 07 November 1983 ROC Patna HQ Patna, Bihar, India
Active Public Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2025
₹139.55 Cr
▲ 11% YoY
Net profit · FY 2025
₹1.1 Cr
Net margin 0.8%
EBITDA · FY 2025
₹5.78 Cr
EBITDA margin 4.1%
Authorised capital
₹4.5 Cr
Registered with MCA
Paid-up capital
₹2.96 Cr
Issued & subscribed
Open charges
₹42 Cr
Satisfied ₹94.02 Cr
Company age
43 yrs
Est. 1983
Employees · EPFO
1,047
Provident fund records

About Aglowmed Limited

Data last updated:

Aglowmed Limited is a public limited company based in Patna, Bihar, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 November 1983 and has been in existence for over 43 years.

The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24232BR1983PLC001901. Its GSTIN is 10AABCA9519L1ZR (Bihar). The company holds 22 GST registrations, of which 12 are active.

The company has an authorised share capital of ₹4.5 Cr and a paid-up capital of ₹2.96 Cr. It was formerly known as Aglowmed Private Limited. It is led by directors including Ashok Sharma (Managing Director) and Praveen Sharma.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 271 Patliputra Colony, Patna, Bihar, India – 800013.

As per the financials filed for FY 2025, the company reported a revenue of ₹139.55 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹1.1 Cr (net margin 0.8%) and EBITDA of ₹5.78 Cr (EBITDA margin 4.1%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 11% over five years.

The company has about 1,047 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Aglowmed. As per MCA filings, the company has open charges of ₹42 Cr and satisfied charges of ₹94.02 Cr on record. Court records list 315 cases involving the company, including 180 filed by the company and 135 filed against it; 72 cases are pending. The company has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.76 Cr; the latest was in March 2024. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Sovereign Pharma Private Limited with revenue of ₹142.09 Cr.

Aglowmed Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0122113). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aglowmed.com.

Company details

CIN U24232BR1983PLC001901
Registration Number 001901
Incorporation Date 07 November 1983
ROC Patna
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0122113

CIN history

Aglowmed has one previous CIN (Corporate Identification Number): U24230BR1983PTC001901. The current CIN is U24232BR1983PLC001901, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232BR1983PLC001901Current
U24230BR1983PTC001901Previous

Recognitions & Rankings of Aglowmed

MSME (Udyam registered) Ministry of MSME
Category
Medium (2022-23)
Udyam number
UDYAM-MH-19-0122113

Contact details

Aglowmed Limited's registered office is in Patna, Bihar. Its website is aglowmed.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    271 Patliputra Colony, Patna, Bihar, India – 800013
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Aglowmed Limited, buy the company report.

Comprehensive company report
Aglowmed Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Aglowmed operates one associated brand: Aglowmed. Each brand links to its own profile.

BrandDescriptionWebsite
Specializes in manufacturing and distributing pharmaceutical products and services.aglowmed.com

Business activity

The main business activity of Aglowmed is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Aglowmed Limited, buy the company report.

Financials of Aglowmed Limited

FY 2025 filings available

Aglowmed Limited reported revenue of ₹139.55 Cr (up 11% YoY) for FY 2025.

Revenue · FY 2025
₹139.55 Cr ▲ 11%
Net profit · FY 2025
₹1.1 Cr margin 0.8%
EBITDA · FY 2025
₹5.78 Cr margin 4.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 10%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 6%
5 years · compounded
▲ 1%

Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 11% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹5.78 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.1 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin4.1%
Net Profit Margin0.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Aglowmed Limited, buy the company report.

Board of directors of Aglowmed Limited

Aglowmed has 6 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Praveen SharmaDirector10 Sep 200422 Years 1 MonthsCurrent
Gyan PrakashAdditional Director03 Oct 20233 Years 0 MonthsCurrent
Aihshan SharmaDirector09 Sep 200917 Years 1 MonthsCurrent
Ashok SharmaManaging Director25 Aug 200323 Years 1 MonthsCurrent
Abhishek KumarAdditional Director15 Jan 20242 Years 9 MonthsCurrent
Abeejayh Ashok Kumar SharmaDirector21 Sep 20179 Years 1 MonthsCurrent

Peer comparison

Aglowmed Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Sovereign Pharma Private Limited₹142.09 Cr (FY 2025)15.0%Mumbai, Maharashtra, India
Svizera Labs Private Limited₹142.05 Cr (FY 2022)7.0%Thane, Maharashtra, India
Ratnatris Pharmaceuticals Private Limited₹141.71 Cr (FY 2025)35.0%Ahmedabad, Gujarat, India
Lyka Labs Limited₹140.73 Cr (FY 2025)25.0%Ankleshwar, Gujarat, India
Aglowmed Limitedthis company₹139.55 Cr (FY 2025)₹1.1 Cr0.8%11.0%1,047Patna, Bihar, India
Jackson Laboratories Private Limited₹139.35 Cr (FY 2024)14.0%Punjab, India
Ontop Pharmaceuticals Private Limited₹138.93 Cr (FY 2024)4.0%Hosur Road, Bangalore, Karnataka, India
Sundyota Numandis Probioceuticals Private Limited₹138.84 Cr (FY 2025)24.0%Ahmedabad, Gujarat, India
M.M. Remedies Private Limited₹137.33 Cr (FY 2025)10.0%Llucknow, Uttar Pradesh, India

To see the full peer comparison of Aglowmed Limited, buy the company report.

Auditor

Aglowmed Limited is audited by A A Pathak and Company for the financial year 2024.

Auditor firmFinancial yearFirm registration number
A A Pathak and CompanyFY 2024019448C

Shareholding

The shareholding of Aglowmed Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Aglowmed Limited, buy the company report.

Charges & borrowings

Open charges
₹42 Cr
Satisfied charges
₹94.02 Cr
Breakdown by lending institutions
Others₹40.58 Cr
Hdfc Bank Limited₹1.42 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
24 Oct 2025101185120Hdfc Bank Limited₹22.65 LakhOpen
29 Jan 2024100925086Hdfc Bank Limited₹1.19 CrOpen
30 Apr 2022100585698Others₹12 CrOpen
16 Jul 2020100397630Others₹3.75 CrOpen
14 May 2019100261894Others₹5.33 CrOpen

To see the full charge records of Aglowmed Limited, buy the company report.

Total charge records: 43 View all charges

Deals & funding

Aglowmed Limited has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.76 Cr; the latest was in March 2024.

Total deals
6
Funding rounds
4
Secondary share transfers
2
Disclosed funding
₹1.76 Cr

Deals on record (5 of 6)

WhenDealAmountParties
Mar 2024Funding round₹45 LakhInvestors: 3 individuals
Feb 2022Funding round₹51.4 LakhInvestors: 4 individuals
Mar 2013Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Jul 2011Funding round₹19.6 LakhInvestors: 2 individuals
Mar 2007Secondary share transferUndisclosedBuyer: an individual
Seller: an individual

To see the full deal history of Aglowmed Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Aglowmed Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Aglowmed Limited has a workforce of 1,047 employees on its EPFO records as of Feb 18, 2025, across 2 active EPFO establishments.

Employee count
1,047
Active EPFO establishments
2
Employee growth
8.84%

GST

Aglowmed has 22 GST registrations: 12 active and 10 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
22
Active
12
Cancelled / inactive
10
GSTINStateStatusRegistered on
10AABCA9519L1ZRBiharActive01 Jul 2017
05AABCA9519L2ZHUttarakhandActive01 Jul 2017
08AABCA9519L1ZCRajasthanActive01 Jul 2017
09AABCA9519L1ZAUttar PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Aglowmed Limited, buy the company report.

Recent activity

Aglowmed Limited has 8 board changes on record since 2003: 6 appointments and 2 cessations. The latest: Tanuja Sharma ceased to be Director on 19 May 2024.

Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.23 Cr with Charge ID 101185120 was registered on 24 Oct 2025.
AGM
Aglowmed Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aglowmed Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Patna.
Charges
A charge with Others of Rs. 12.00 Cr registered on 30 Apr 2022 with Charge ID 100585698 was modified on 22 Jan 2025.
Ceased
Tanuja Sharma ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.19 Cr with Charge ID 100925086 was registered on 29 Jan 2024.
Appointed
Abhishek Kumar was appointed as Additional Director.
Appointed
Gyan Prakash was appointed as Additional Director.
Charges
A charge with Others amounted to Rs. 12.00 Cr with Charge ID 100585698 was registered on 30 Apr 2022.
Charges
A charge with Others amounted to Rs. 3.75 Cr with Charge ID 100397630 was registered on 16 Jul 2020.
Charges
A charge with Others amounted to Rs. 5.33 Cr with Charge ID 100261894 was registered on 14 May 2019.
Charges
A charge registered on 31 Jan 2018 via Charge ID 100165116 with Others was fully satisfied on 10 Jan 2019.

84 earlier events are in the company report.

Frequently asked questions

Aglowmed is an active public limited company based in Patna, Bihar, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 November 1983 (43+ years old) and is registered under CIN U24232BR1983PLC001901.

Aglowmed has 6 current directors:

The latest financial statements of Aglowmed on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Aglowmed is 10AABCA9519L1ZR, registered in Bihar. The company has 22 GST registrations in all, of which 12 are active and 10 are cancelled or inactive. Other active GSTINs include 05AABCA9519L2ZH (Uttarakhand), 08AABCA9519L1ZC (Rajasthan), 09AABCA9519L1ZA (Uttar Pradesh).

The CIN (Corporate Identification Number) of Aglowmed is U24232BR1983PLC001901. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Aglowmed has 315 court cases on record: 180 filed by the company and 135 filed against it. 72 are pending. Most are in the district courts.

Aglowmed was incorporated on 07 November 1983, making it 43+ years old. It is registered with the Registrar of Companies, Patna.

Aglowmed has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.76 Cr; the latest was in March 2024.

The peers of Aglowmed by revenue are Sovereign Pharma Private Limited, Svizera Labs Private Limited, Ratnatris Pharmaceuticals Private Limited, Lyka Labs Limited, Jackson Laboratories Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Tanuja Sharma ceased to be Director on 19 May 2024. Abhishek Kumar was appointed as Additional Director on 15 Jan 2024. Gyan Prakash was appointed as Additional Director on 03 Oct 2023. Aglowmed has 8 board changes on record in total.

Yes, Aglowmed is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0122113).